The Delhi High Court Tuesday sought a response from Novo Nordisk as to why its patent on diabetes and anti-obesity drug semaglutide should not be revoked-a direction sought by ...
Last Updated:December 23, 2025, 13:27 ISTThe FDA has approved the first daily pill for obesity, Wegovy, giving Novo Nordisk an edge over Eli Lilly in offering an oral weight-loss ...